Topics
Glioblastoma | Diagnosis | Biomarkers | Overview
Home > Publications > Topics > Glioblastoma > Diagnosis > Biomarkers > Overview
Katole VR, Kaple M.
Unraveling the
Landscape of Pediatric Glioblastoma Biomarkers: A Comprehensive
Review of Enhancing Diagnostics and Therapeutic Insights.
Cureus.
2024 Mar 30;16(3):e57272. doi:
10.7759/cureus.57272. PMID:
38686271. Review. ˍ
*Gonçalves JM, Carvalho B, Tuna R, Polónia P,
Linhares P.
Sequential Evaluation of
Hematology Markers as a Prognostic Factor in Glioblastoma
Patients.
Biomedicines.
2024 May 12;12(5):1067. doi:
10.3390/biomedicines12051067. PMID:
38791033. Observational study. ˍ
John
D, Alshalalfa M, Almeida T, Murray A, Marques J, Azzam G, Mellon
EA, Benjamin CG, Komotar RJ, Ivan M, Mahal B, Rich BJ.
Racial
Disparities in Glioblastoma Genomic Alterations: A Comprehensive
Analysis of a Multi-institution Cohort of 2,390 patients.
World
Neurosurg.
2024 Jun 4:S1878-8750(24)00945-8. doi:
10.1016/j.wneu.2024.05.183. PMID:
38843966. Observational study˰ ˍ
Tataranu LG, Turliuc S, Rizea RE, Dricu A, Alexandru O, Staicu GA,
Kamel A.
A Synopsis of Biomarkers in
Glioblastoma: Past and Present.
Curr
Issues Mol Biol. 2024 Jul 3;46(7):6903-6939. doi:
10.3390/cimb46070412. PMID:
39057054. Review. ˍ
van Opijnen MP, de Vos FYF, Cuppen E, Geurts M, Maas SLN, Broekman
MLD.
The role of molecular biomarkers
in recurrent glioblastoma trials: an assessment of the current
trial landscape of genome-driven oncology.
Med
Oncol. 2024 Sep 24;41(11):250. doi:
10.1007/s12032-024-02501-7. PMID:
39316248. Observational study. ˍ
Jacome MA, Wu Q, Piña Y, Etame AB.
Evolution
of Molecular Biomarkers and Precision
Molecular Therapeutic Strategies in Glioblastoma.
Cancers
(Basel). 2024 Oct 29;16(21):3635. doi:
10.3390/cancers16213635. PMID:
39518074. Review. ˍ